As regulators examine the on-body injector used with isatuximab in multiple myeloma, Sikander Ailawadhi, MD, provides commentary on frequently asked questions. The European Medicines Agency’s ...
The U.S. Food and Drug Administration (FDA) on Wednesday delayed its decision on Sanofi SA’s SNY subcutaneous Sarclisa ...
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...
Sikander Ailawadhi, MD, of the Mayo Clinic Florida in Jacksonville, discusses the clinical significance and primary outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results